Pipeline

DEVELOPMENT PROGRAMS

Advancing tumor-directed immunotherapies for immune-cold, therapy-resistant cancers.

Program

Focus

Strategy

Stage

MOD2 — LEAD

Prostate cancer

Tumor-directed immune modulation

Lead optimization

MOD4

TNBC •Prostate cancer • Other solid-tumors

Conditional masking

Discovery

MOD3

Ovarian

Conditional masking

Discovery

TABI™ Expansion

Additional immune-cold solid tumors

Next-generation programs

Exploratory